The total number of records retrieved from this search are 5. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_5450	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineTohuku university Japan	Origin of cell lineHuman pancreatic cancer cell line	Cell linePK9	Concentration of cell lineNA	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result90% cell viable after day 2	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27561180
IDOV_5451	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineTohuku university Japan	Origin of cell lineHuman pancreatic cancer cell line	Cell linePK9	Concentration of cell lineNA	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result90% cell viable after day 4	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27561180
IDOV_5452	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineTohuku university Japan	Origin of cell lineHuman pancreatic cancer cell line	Cell linePK9	Concentration of cell lineNA	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result70% cell viable after day 6	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27561180
IDOV_5453	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineTohuku university Japan	Origin of cell lineHuman pancreatic cancer cell line	Cell linePK9	Concentration of cell lineNA	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result60% cell viable after day 8	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27561180
IDOV_5454	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineTohuku university Japan	Origin of cell lineHuman pancreatic cancer cell line	Cell linePK9	Concentration of cell lineNA	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result60% cell viable after day 10	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27561180